adenocarcinoma
Showing NaN - NaN of 14
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Feb 8, 2022
NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)
Terminated
- Non-Small Cell Lung Cancer
- +3 more
-
Tucson, Arizona
- +34 more
Oct 11, 2021
Clinical Management of Esophageal Adenocarcinoma (EAC)
Active, not recruiting
- Esophageal Cancer
- Adenocarcinoma
- serum and tissue mesothelin
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 1, 2021
Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)
Completed
- Gastric Cancer
- Adenocarcinoma
- ramucirumab
- +2 more
-
Bakersfield, California
- +160 more
Sep 10, 2019
Adenocarcinoma Trial in United States (Bevacizumab, Capecitabine, Cisplatin)
Barrett Syndrome, Barrett's Syndrome, Barrett's Esophagus Trial in France, Germany, United States (Imaging procedures (NBI),
Completed
- Barrett Syndrome
- +4 more
- Imaging procedures (NBI)
- +2 more
-
Jacksonville, Florida
- +4 more
May 2, 2016
Colorectal Polyps, Colorectal Adenoma, Adenocarcinoma Trial in New York ( and Calcitriol, Calcium and Calcitriol)
Completed
- Colorectal Polyps
- +2 more
- placebo and Calcitriol
- Calcium and Calcitriol
-
New York, New YorkRockefeller University Hospital
Nov 17, 2011
Prostate Cancer, Adenocarcinoma Trial in Worldwide (Atrasentan)
Completed
- Prostate Cancer
- Adenocarcinoma
-
Marina Del Rey, California
- +14 more
Nov 28, 2007